Abstract
Endothelin-1 is a potent vasoconstrictor in the body. Previous studies have identified associations between the coding polymorphism K198N and hypertension, systolic blood pressure and HDL levels. We sought to examine the evidence for these associations and, additionally, the association between K198N, insulin resistance, metabolic syndrome and coronary artery disease (CAD). We used generalised linear modelling to test K198N for association with hypertension and systolic blood pressure, lipid levels, insulin resistance scores and metabolic syndrome in a general cross-sectional community sample. Mean carotid intima media thickness and risk of carotid plaque were examined in the general population sample, and Gensini score was examined in a sample of patients with CAD. A case/control sample was used to examine the association of K198N with risk of CAD. There was no significant evidence for association between K198N and hypertension, systolic blood pressure, lipid levels, insulin resistance or metabolic syndrome in either population. The minor allele was marginally associated with increased mean IMT levels (P = 0.02) in the general population sample, although not with CAD in the case/control study or with the severity of disease in patients with CAD. In conclusion, we found no robust evidence for the associations between K198N and hypertension, systolic blood pressure or HDL levels seen in previous studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberti KG, Zimmet P, Shaw J (2005) IDF epidemiology task force consensus group: the metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062
Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, Hozawa A, Matsubara M, Kitaoka H, Tsuji I, Araki T, Satoh H, Hisamichi S, Imai Y, Ogihara T (2001) Endothlin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 38:1321–1324
Carter KW, McCaskie PA, Palmer LJ (2006) JLIN: a Java based linkage disequilibrium plotter. BMC Bioinformatics 7:60
Chapman CM, Palmer LJ, McQuillan BM, Hung J, Burley J, Hunt C, Thompson PL, Beilby JP (2001) Polymorphisms in the angiotensinogen gene are associates with carotid intimal-media thickening in females from a community-based population. Atherosclerosis 159:209–217
Dupont WD, Plummer WD (1990) Power and sample size calculations: a review and computer program. Control Clin Trials 11:116–128
Endeman DK, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992
Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606
Grundy SM, Brewer B Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438
Irving RJ, Noon JP, Watt GC, Webb DJ, Walker BR (2001) Activation of the endothelin system in insulin resistance. QJM 94:321–326
Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Tabara Y, Yamamoto Y, Igase M, Kohara K, Miki T (2003) Association of endothelin-1 gene variant with hypertension. Hypertension 41:163–167
Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846
Kanaya AM, Barret-Connor E, Wassel Fyr CL (2007) Endothelin-1 and prevalent coronary heart disease in older mend and women (The Rancho Bernardo Study). Am J Cardiol 4:486–490
Langleben D (2007) Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Clin Chest Med 28:117–125
Luscher TF, Barton M (2000) Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102:2434–2440
Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
McCaskie PA, Cadbuy G, Hung J, McQuillan BM, Chapman CML, Carter KW, Thompson PL, Palmer LJ, Beilby (2006) The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease. Clin Genet 70:114–121
McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J (1999) Hyperhomocysteinaemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 99:2838–2888
Paré G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, Engert JC, Hudson TJ, Gaudet D (2007) Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high density lipoprotein cholesterol. Am J Hum Genet 80:673–682
Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150
Shah R (2007) Endothelins in health and disease. Eur J Int Med 18:272–282
Strawbridge AB, Elmendorf JS (2005) Phosphatidylinositol 4,5 bisphosphate reverse endothelin-1 induced insulin resistance via an actin-dependent mechanism. Diabetes 54:1698–1705
Strawbridge AB, Elmendorf JS (2006) Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism. J Cell Biol 97:849–856
Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJV, Dargie HJ, Arveiler D, Ruidavets J-B, Luc G, Evans A, Cambien F (1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33:1169–1174
Acknowledgments
The authors thank the participants of the CUPID and CUDAS cross sectional studies. This study was supported by grants-in-aid from the National Heart Foundation grant-in-aid G97P 5002. K.W.C. was supported by a Post-doctoral Fellowship from the Australian Research Council. B.L.P. was supported by a Howard Florey Fellowship from the National Health and Medical Research Council of Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiltshire, S., Powell, B.L., Jennens, M. et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease. Hum Genet 123, 307–313 (2008). https://doi.org/10.1007/s00439-008-0481-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-008-0481-0